To describe the rate of fellow eye vitrectomy for proliferative diabetic retinopathy in an inner city population. Methods Retrospective interventional case series. Medical and surgical records of 434 consecutive eyes of 358 patients undergoing primary diabetic vitrectomy in an inner city institutional practice were reviewed. Kaplan-Meier statistical analysis was employed to evaluate the rate of fellow eye vitrectomy and visual outcomes were determined for patients with ≥3 months follow-up. Results Fellow eyes underwent diabetic vitrectomy at a rate of 24% within 1 year, 34% within 3 years and 36% within 5 years of primary vitrectomy. A surgical indication of non-clearing vitreous haemorrhage (VH) in the primary eye was associated with a lower rate of fellow eye surgery compared with non-clearing VH with extrafoveal traction retinal detachment (TRD) at years 1, 3 and 5 ( p≤0.02), and TRD at years 3 and 5 (p≤0.03). Younger patients underwent fellow eye vitrectomy at a higher rate than older patients ( p≤0.01). Surgical intervention was associated with improvement in mean visual acuity ( p<0.01). Conclusions Approximately a third of fellow eyes required diabetic vitrectomy within 3 years of primary eye vitrectomy. Primary eye surgical indication and younger age were significant predictors of need for fellow eye surgery.
INTRODUCTION
Diabetic retinopathy is a leading cause of visual morbidity and affects approximately 4.1 million adults in the USA. 1 The incidence of retinopathy is expected to rise precipitously as a consequence of the ageing population and the increase in age-specific disease prevalence. 1 In advanced proliferative diabetic retinopathy (PDR), surgical intervention is often employed to clear media opacities, relieve traction, treat retinal breaks and stabilise the proliferative process. 2 For patients undergoing diabetic vitrectomy, the status of the fellow eye and potential need for future surgical intervention are a significant concern. However, few studies 2 3 have attempted to evaluate the need for surgical intervention in the fellow eye, despite the bilateral nature of the disease. The goal of this study was to describe the rate of fellow eye vitrectomy for PDR in an inner city population.
METHODS
The medical and surgical records of consecutive patients who underwent primary pars plana vitrectomy for complications relating to PDR by a single surgeon (DE) at the Kresge Eye Institute of Wayne State University School of Medicine (Detroit, Michigan, USA) were reviewed retrospectively. All patients underwent standard 3-port pars plana vitrectomy for non-clearing vitreous haemorrhage alone (VH), non-clearing vitreous haemorrhage with extrafoveal traction retinal detachment (VHTRD), traction retinal detachment involving the fovea (TRD) with or without VH, combined traction and rhegmatogenous retinal detachment (TRRD), or neovascular glaucoma (NVG). Preoperative and postoperative best-corrected Snellen vision was converted to logarithm of the minimum angle of resolution (logMAR) units to facilitate statistical comparison. Functional outcome was determined by visual acuity at last follow-up for patients with at least 3 months follow-up.
Numerical computations were performed using a spreadsheet package (Excel 2003; Microsoft, Redmond, Washington, USA). Statistical comparison of categorical findings was performed using the χ 2 test. Kaplan-Meier statistical analysis and survival curve for fellow eye surgery were performed using public domain statistical software (Epi Info V.3.5.3; Centers for Disease Control and Prevention, Atlanta, Georgia, USA). A p value of ≤0.05 was considered statistically significant.
This study followed the tenets of the Declaration of Helsinki and received approval from the institutional review board of Wayne State University School of Medicine. Medical charts were reviewed in compliance with the Health Insurance Portability and Accountability Act.
RESULTS
A total of 434 consecutive eyes of 358 patients underwent primary pars plana vitrectomy for complications related to PDR. A subset of 315 eyes of 260 patients had at least 3 months of follow-up. Patient demographics were analysed for primary and fellow eyes (table 1) .
The overall rate of surgical intervention on the fellow eye was 21% for all patients (76/358) and 21% for patients with at least 3 months follow-up (55/260). Mean and median follow-up duration was 23 and 13 months for all eyes, respectively, and 31 and 23 months for eyes with at least 3 months of follow-up, respectively. There was no significant difference in gender or laterality of eye between the two groups.
Patients requiring vitrectomy on both eyes were significantly younger than patients requiring surgery on the primary eye only. Overall, the mean age for primary and fellow eye vitrectomy was 55 and 50 years ( p<0.01), respectively, and the median age for primary and fellow eye vitrectomy was 56 and 52 years, respectively. Patients with at least 3 months follow-up demonstrated a similar trend, with a mean age for primary and fellow eye vitrectomy of 54 and 50 years ( p=0.06), respectively, and a median age for primary and fellow eye vitrectomy of 55 and 52 years, respectively. Subgroup analysis stratifying patients into younger (<40 years) and older groups (≥40 years) revealed a higher rate of fellow eye surgery in the younger group (35% vs 19%) for all eyes ( p=0.05).
The most common indication for diabetic vitrectomy was VHTRD followed by TRRD, TRD, VH and NVG. Surgical indications were similar between all eyes and eyes with at least 3 months follow-up (table 2) .
There was no significant difference in surgical indications between the younger and older groups. For each subgroup, there was no significant difference in surgical indication between primary eyes and fellow eyes.
Overall, surgical intervention resulted in a significant improvement in visual acuity for eyes with at least 3 months follow-up (table 3) .
Mean visual acuity improved from A Kaplan-Meier survival curve was constructed because of variable follow-up duration (figure 1). Overall, the percentage of patients who did not require fellow eye surgery was 76% at 1 year, 66% at 3 years and 64% at 5 years (table 4) .
Patients undergoing vitrectomy in the primary eye for VH had significantly less risk for fellow eye surgery compared with those who underwent intervention for VHTRD at years 1, 3 
DISCUSSION
The goal of this study was to determine the rate of fellow eye vitrectomy for patients with advanced PDR in an inner city population. Our analysis revealed that fellow eyes underwent diabetic vitrectomy at a rate of 24% within 1 year, 34% within 3 years and 36% within 5 years of primary eye surgery, despite attempted close follow-up and extensive application of panretinal photocoagulation. Median time to fellow eye surgery (all eyes) was 5.6 months, and mean time was 10.5 months. Younger patients (<40 years) were at higher risk for requiring fellow eye diabetic vitrectomy compared with older patients (≥40 years) at years 1, 3 and 5 ( p≤0.01). We identified the surgical indication of the primary eye as an important predictor of whether surgery would be required for the fellow eye. Patients who underwent vitrectomy for nonclearing VH demonstrated significantly lower rates of fellow eye surgery compared with patients with VHTRD at years 1, 3 and 5 (p≤0.02), TRD at years 3 and 5 (p≤0.03), and a trend towards lower risk relative to TRRD at year 5 ( p=0.07). These findings were not surprising, given that non-clearing VH represents the mildest manifestation of PDR requiring vitrectomy. Since PDR is a bilateral disease, albeit often asymmetric, it is reasonable to assume that primary eyes with less advanced disease are less likely to require vitrectomy on the fellow eye.
Patients undergoing surgical intervention experienced significant visual benefits (table 3) . Overall, mean visual acuity improved from 1.75 logMAR (20/1125) to 1.51 logMAR (20/647) ( p<0.01), and median visual acuity improved from 1.60 logMAR (20/796) to 1.30 logMAR (20/399). Subgroup analysis demonstrated that primary eyes had an improvement in mean visual acuity ( p<0.01), whereas fellow eyes had a trend towards improvement ( p=0.09). Visual acuity distributions were significantly improved postoperatively for all eyes, primary eyes and fellow eyes ( p≤0.03), and approximately 50% of eyes experienced a visual acuity gain of ≥0.3 logMAR. These findings are consistent with previous studies that assessed functional outcomes following diabetic vitrectomy. This study also highlights the perils of reporting proportions in clinical studies: a commonly employed but potentially misleading analytical method. 7 In our study, 21% of patients (76/358) required diabetic vitrectomy in the fellow eye. Yet, we reported that 36% of patients required fellow eye surgery within 5 years of primary eye vitrectomy. This difference can be attributed to the fact that use of proportions or percentages in a population does not account for variable follow-up or the effect of time. If all 358 patients were followed up to 5 years, then it would be appropriate to report that 21% (76/358) of patients required fellow eye surgery at 5 years. However, since some patients were lost to follow-up, the population that potentially needed fellow eye surgery at 5 years was significantly smaller. In this scenario, Kaplan-Meier survival analysis was appropriately employed to account for variable follow-up duration.
4-6
Previous studies have attempted to evaluate the rate of fellow eye surgery in PDR. A report 2 from the Bascom Palmer Eye Institute, which focused primarily on assessing the impact of vitrectomy on overall visual function, reported as a secondary outcome that 24% of fellow eyes required diabetic vitrectomy at final follow-up (mean of 17.6 months, range of 3-79 months). At final follow-up, 79% of all fellow eyes demonstrated a visual acuity of ≥5/200, and 23% experienced visual loss that was defined as halving of the visual angle or no light perception vision. However, this study had a relatively short mean follow-up duration of 17.6 months, and the variable follow-up of the study population precluded a detailed interpretation of the rate of fellow eye vitrectomy. 7 Our study demonstrated a longer mean follow-up period of 23 months for all eyes and 31 months for eyes with at least 3 months of follow-up, and employed KaplanMeier survival analysis to account for variable follow-up.
Another study 3 conducted in New Zealand on a predominantly Maori and Pacific Islander population reported that 38% of fellow eyes required diabetic vitrectomy with a mean time of 1.6 years following primary eye surgery (mean follow-up of 4 years, range of 1 day-8.4 years). The study correlated the absence of VH (ie, TRD or TRRD alone without VH) as a significant predictor of need for fellow eye surgery compared with the presence of VH (with or without TRD or TRRD). The report also identified the duration of diabetes and poor diabetic control as independent predictors of time to fellow eye surgery. Of note, the population in this study was in particularly poor health and 57% of patients had died at the time of data analysis (mean of 4.3 years following surgery).
It is important to note that our study population is not representative of the general population, since our patients were predominantly inner city, uninsured and underinsured (Medicaid), and African American (75%). Cardiovascular morbidities were common in our population with high rates of prior myocardial infarction and congestive heart failure, and many patients had chronic renal failure requiring renal dialysis. In addition, our patients had low rates of prior ophthalmic care and panretinal photocoagulation on initial presentation. The reasons underlying patient loss to follow-up are likely multifactorial and attributable to a combination of socioeconomic, educational, systemic health and insurance-related issues. Patients lost to follow-up may have experienced a different rate of fellow eye disease, and this is a possible confounder in our study.
In summary, in this primarily urban, underinsured, African American patient population with complex vitreoretinal pathology due to severe complications of PDR, patients who underwent diabetic vitrectomy were at significant risk for requiring surgical intervention on the fellow eye despite attempted close follow-up and extensive panretinal photocoagulation. Approximately a third of fellow eyes underwent diabetic vitrectomy within 3 years of primary eye vitrectomy. Patients who underwent vitrectomy for non-clearing VH in the primary eye had a significantly lower risk of requiring fellow eye surgery compared with those who underwent surgery for VHTRD and TRD. Younger patients were at significantly higher risk of needing surgical intervention on the fellow eye.
Contributors All authors ( JCH, AGS and DE) contributed through (1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published. DE is responsible for the overall content as guarantor.
Funding None.
Competing interests None.
Ethics approval Wayne State University School of Medicine.
Provenance and peer review Not commissioned; externally peer reviewed.
